Top Globe News – Lifestyle

Author: Amplia Therapuetics Limited

Accent Trial Mature Data Presented at International Conference

April 24, 2026
Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models

March 26, 2026
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

March 23, 2026